Hu Qiang, Teng Yuan, Yuan Yuan, Gao Guodong, Ji Bingyang
Department of Cardiopulmonary Bypass, National Center for Cardiovascular Diseases & Fuwai Hospital, Peking Union Medical College & Chinese Academy of Medical Sciences, 10037 Beijing, China.
Interdiscip Cardiovasc Thorac Surg. 2025 Sep 1;40(9). doi: 10.1093/icvts/ivaf177.
Deep hypothermic circulatory arrest (DHCA) is known to trigger a systemic inflammatory response and ischaemia-reperfusion injury, leading to exacerbated lung dysfunction. Ulinastatin (UTI) is a commonly used anti-inflammatory drug in clinical settings, but its protective effects may vary depending on the timing and dosage.
A rat model of DHCA was established, and 2 different doses of UTI (5/10 × 104 U/kg; low/high dose) were administered. We measured the levels of inflammatory factors using enzyme-linked immunosorbent assay kits and assessed the functional indicators of lung tissue injury. All rats (n = 18) underwent the standard cardiopulmonary bypass (CPB) procedure with DHCA.
Following rewarming, the levels of interleukin-6 (IL-6), IL-10, tumour necrosis factor (TNF)-α, and neutrophil elastase 2 (ELA-2) gradually increased in rats exposed to DHCA. Compared to the DHCA group, both the UTI groups exhibited significant reductions in IL-6 (DHCA vs DHCA+UTI-H, 8931.68 ± 650.31 vs 2498.05 ± 552.16), TNF-α (DHCA vs DHCA+UTI-H, 633.74 ± 74.53 vs 221.19 ± 31.63), and ELA-2 (DHCA vs DHCA+UTI-H, 4.94 ± 0.49 vs 3.29 ± 0.34), while remarkably increased the IL-10 (DHCA vs DHCA+UTI-H, 975.04 ± 110.33 vs 3081.27 ± 554.10) levels 4 hours after weaning from CPB (all P < 0.05). Interestingly, the high dose of UTI demonstrated a dose-dependent inhibition of inflammation. Meanwhile, we found that UTI contributed to maintain haemodynamic stability, improve tissue perfusion, and reduce hypoxia, as evidenced by elevated heart rate, blood pressure, haematocrit and oxygenation index, and decreased glucose and lactate. Reduced pathological changes in lung histopathology were also observed after UTI intervention, especially in 10 × 104 U/kg group.
This study revealed that administration of low to high doses of UTI during DHCA could reduce the release of inflammatory factors, exert anti-inflammatory effects, and alleviate lung injury.
已知深度低温循环停搏(DHCA)会引发全身炎症反应和缺血再灌注损伤,导致肺功能障碍加剧。乌司他丁(UTI)是临床常用的抗炎药物,但其保护作用可能因给药时间和剂量而异。
建立DHCA大鼠模型,并给予2种不同剂量的UTI(5/10×104 U/kg;低/高剂量)。我们使用酶联免疫吸附测定试剂盒测量炎症因子水平,并评估肺组织损伤的功能指标。所有大鼠(n = 18)均接受了采用DHCA的标准体外循环(CPB)手术。
复温后,接受DHCA的大鼠体内白细胞介素-6(IL-6)、IL-10、肿瘤坏死因子(TNF)-α和中性粒细胞弹性蛋白酶2(ELA-2)水平逐渐升高。与DHCA组相比,两个UTI组的IL-6(DHCA组与DHCA+UTI-H组,8931.68±650.31 vs 2498.05±552.16)、TNF-α(DHCA组与DHCA+UTI-H组,633.74±74.53 vs 221.19±31.63)和ELA-2(DHCA组与DHCA+UTI-H组,4.94±0.49 vs 3.29±0.34)水平均显著降低,而在CPB撤机4小时后IL-10水平显著升高(DHCA组与DHCA+UTI-H组,975.04±110.33 vs 3081.27±554.10)(所有P<0.05)。有趣的是,高剂量的UTI表现出剂量依赖性的炎症抑制作用。同时,我们发现UTI有助于维持血流动力学稳定、改善组织灌注并减轻缺氧,表现为心率、血压、血细胞比容和氧合指数升高,以及血糖和乳酸降低。UTI干预后还观察到肺组织病理学的病理变化减轻,尤其是在10×104 U/kg组。
本研究表明,在DHCA期间给予低至高剂量的UTI可减少炎症因子的释放,发挥抗炎作用,并减轻肺损伤。